P2Y₁₂ antibody inhibits platelet activity and protects against thrombogenesis

Keyphrases

• P2Y12 100%
• P2Y12 Receptor 100%
• Thrombogenesis 100%
• Platelet Activity 100%
• Antiplatelet Therapy 66%
• Adenosine Diphosphate 66%
• Platelets 33%
• Receptor Agonist 33%
• Clinical Application 33%
• Ligand-binding Domain 33%
• In Vitro Study 33%
• P-selectin 33%
• In Vitro Activity 33%
• G Protein-coupled 33%
• Drug Target 33%
• Thrombosis 33%
• Thrombus Formation 33%
• FACS Analysis 33%
• In Vivo Effects 33%
• P2Y Receptors 33%
• U46619 33%
• Antiplatelet Agents 33%
• Thrombotic 33%
• Phosphatidylserine Exposure 33%
• Antiplatelet Activity 33%
• Integrin Activation 33%
• Bleeding Time 33%
• Bleeding Diathesis 33%
• Antibody Targeting 33%
• Inhibitory Profile 33%
• Thromboxane Receptor 33%
• Platelet Hyperactivity 33%
• Cangrelor 33%
• Aggregation-induced 33%

Medicine and Dentistry

• Platelet 100%
• Blood Clotting 100%
• Antiplatelet 75%
• Purinergic P2Y12 Receptor 75%
• In Vitro 50%
• Thrombosis 50%
• Adenosine Diphosphate 50%
• Receptor 25%
• Integrin 25%
• Drug Delivery System 25%
• Hyperactivity 25%
• Ligand Binding 25%
• PADGEM Protein 25%
• Guanine Nucleotide Binding Protein 25%
• Fluorescence Activated Cell Sorting 25%
• Phosphatidylserine 25%
• Bleeding Time 25%
• Antiplatelet Drug 25%
• Bleeding Diathesis 25%
• 15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid 25%
• Purinergic P2Y1 Receptor 25%
• Thromboxane Receptor Stimulating Agent 25%
• Cangrelor 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiplatelet 100%
• Purinergic P2Y12 Receptor 100%
• Thrombosis 66%
• Adenosine Diphosphate 66%
• Receptor 33%
• Integrin 33%
• Drug Delivery System 33%
• P-Selectin 33%
• Bleeding 33%
• Thrombus 33%
• Guanine Nucleotide Binding Protein 33%
• Hyperactivity 33%
• 15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid 33%
• Antithrombocytic Agent 33%
• Fluorescence Activated Cell Sorting 33%
• Phosphatidylserine 33%
• Purinergic P2Y1 Receptor 33%
• Bleeding Tendency 33%
• Cangrelor 33%
• Thromboxane Receptor Stimulating Agent 33%